{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:45:56Z","timestamp":1770039956594,"version":"3.49.0"},"reference-count":63,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1136\/archdischild-2016-312106","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T01:55:16Z","timestamp":1487296516000},"page":"681-686","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Non-topical management of recalcitrant paediatric atopic dermatitis"],"prefix":"10.1136","volume":"102","author":[{"given":"Jin Ho","family":"Chong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Jean Aan","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"key":"key-10.1136\/archdischild-2016-312106-1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1517\/14728214.2014.953927","article-title":"What is new in atopic dermatitis\/eczema?","volume":"19","author":"Pl\u00f6tz","year":"2014","journal-title":"Expert Opin Emerg Drugs"},{"key":"key-10.1136\/archdischild-2016-312106-2","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1136\/bmj.39405.503773.AD","article-title":"Management of atopic eczema in children aged up to 12 years: summary of NICE guidance","volume":"335","author":"Lewis-Jones","year":"2007","journal-title":"BMJ"},{"key":"key-10.1136\/archdischild-2016-312106-3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clindermatol.2014.12.005","article-title":"Systemic therapy of childhood atopic dermatitis","volume":"33","author":"Slater","year":"2015","journal-title":"Clin Dermatol"},{"issue":"1","key":"key-10.1136\/archdischild-2016-312106-4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/bjd.13084","article-title":"Psychodermatological aspects of atopic dermatitis","volume":"170","author":"Senra","year":"2014","journal-title":"Br J Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40272-015-0150-4","article-title":"Systemic agents for severe atopic dermatitis in children","volume":"17","author":"Notaro","year":"2015","journal-title":"Paediatr Drugs"},{"key":"key-10.1136\/archdischild-2016-312106-6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/09546634.2015.1025030","article-title":"Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema","volume":"26","author":"Hon","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"key-10.1136\/archdischild-2016-312106-7","first-page":"28","article-title":"The treatment of severe atopic dermatitis in childhood with narrowband ultraviolet B phototherapy","volume":"32","author":"Clayton","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/bjd.12580","article-title":"Narrowband ultraviolet B phototherapy in children with moderate-to-severe eczema: a comparative cohort study","volume":"170","author":"Darn\u00e9","year":"2014","journal-title":"Br J Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/bjd.14566","article-title":"Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis","volume":"175","author":"Tott\u00e9","year":"2016","journal-title":"Br J Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2230.2006.02061.x","article-title":"Narrowband ultraviolet B (UVB) phototherapy in children","volume":"31","author":"Jury","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.sder.2010.03.006","article-title":"Phototherapy in pediatric patients: choosing the appropriate treatment option","volume":"29","author":"Pugashetti","year":"2010","journal-title":"Semin Cutan Med Surg"},{"key":"key-10.1136\/archdischild-2016-312106-12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.clindermatol.2015.09.009","article-title":"Phototherapy: kids are not just little people","volume":"33","author":"Song","year":"2015","journal-title":"Clin Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.puhe.2014.01.011","article-title":"Review of an established UK home phototherapy service 1998\u20132011: improving access to a cost-effective treatment for chronic skin disease","volume":"128","author":"Cameron","year":"2014","journal-title":"Public Health"},{"key":"key-10.1136\/archdischild-2016-312106-14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2133.1995.tb02725.x","article-title":"Narrowband (TL-01) UVB air-conditioned phototherapy for atopic eczema in children","volume":"133","author":"Collins","year":"1995","journal-title":"Br J Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1525-1470.2003.03016.x","article-title":"Phototherapy in pediatric patients","volume":"20","author":"Pasi\u0107","year":"2003","journal-title":"Pediatr Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0378-6323.148557","article-title":"Phototherapy for atopic dermatitis","volume":"81","author":"Dogra","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"key-10.1136\/archdischild-2016-312106-17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/pde.12405","article-title":"Is phototherapy useful in the treatment of atopic dermatitis in Asian children? A 5-year report from Singapore","volume":"31","author":"Mok","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1525-1470.2003.20617.x","article-title":"Azathioprine as a treatment for severe atopic eczema in children with a partial thiopurine methyl transferase (TPMT) deficiency","volume":"20","author":"Murphy","year":"2003","journal-title":"Pediatr Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2012.07.001","article-title":"Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring","volume":"68","author":"Caufield","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaad.2014.08.048","article-title":"The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring","volume":"72","author":"Fuggle","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00431-012-1893-3","article-title":"Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt","volume":"172","author":"El-Khalawany","year":"2013","journal-title":"Eur J Pediatr"},{"key":"key-10.1136\/archdischild-2016-312106-22","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/ijd.12314","article-title":"Methotrexate for treatment of atopic dermatitis in children and adolescents","volume":"53","author":"Deo","year":"2014","journal-title":"Int J Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2133.2007.07947.x","article-title":"Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients","volume":"157","author":"Heller","year":"2007","journal-title":"Br J Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2133.2000.03241.x","article-title":"Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy","volume":"142","author":"Harper","year":"2000","journal-title":"Br J Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000051694","article-title":"Cyclosporin for atopic dermatitis in children","volume":"203","author":"Harper","year":"2001","journal-title":"Dermatology"},{"key":"key-10.1136\/archdischild-2016-312106-27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jaad.2004.07.043","article-title":"Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature","volume":"52","author":"Dadlani","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-28","doi-asserted-by":"crossref","first-page":"e1735","DOI":"10.1542\/peds.2014-2812","article-title":"Atopic dermatitis: skin-directed management","volume":"134","author":"Tollefson","year":"2014","journal-title":"Pediatrics"},{"key":"key-10.1136\/archdischild-2016-312106-29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1440-0960.2010.00634.x","article-title":"Methotrexate is a safe and effective treatment for paediatric discoid (nummular) eczema: a case series of 25 children","volume":"51","author":"Roberts","year":"2010","journal-title":"Australas J Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1365-2133.2002.04922.x","article-title":"A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression","volume":"147","author":"Murphy","year":"2002","journal-title":"Br J Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jaci.2013.03.016","article-title":"Systemic therapies for severe atopic dermatitis in children and adults","volume":"132","author":"Flohr","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.1136\/archdischild-2016-312106-32","doi-asserted-by":"crossref","unstructured":"Bunikowski R , Mielke M , Brautigam M , et al . Effect of oral cyclosporin A in children with Staphylococcus aureus-colonized vs S. aureus-infected severe atopic dermatitis. Pediatr Allergy Immunol 2003;14:55\u20139.","DOI":"10.1034\/j.1399-3038.2003.02105.x"},{"key":"key-10.1136\/archdischild-2016-312106-33","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1468-3083.2006.02023.x","article-title":"Cyclosporin in the treatment of patients with atopic eczema\u2014a systematic review and meta-analysis","volume":"21","author":"Schmitt","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.1136\/archdischild-2016-312106-34","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0190-9622(96)90281-9","article-title":"Cyclosporine in severe childhood atopic dermatitis: a multicenter study","volume":"34","author":"Berth-Jones","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-35","doi-asserted-by":"crossref","unstructured":"Bunikowski R , Staab D , Kussebi F , et al . Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects. Pediat Allergy Immunol 2001;12:216\u201323.","DOI":"10.1034\/j.1399-3038.2001.012004216.x"},{"key":"key-10.1136\/archdischild-2016-312106-36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/pde.12592","article-title":"Oral cyclosporine weekend therapy: a new maintenance therapeutic option in patients with severe atopic dermatitis","volume":"32","author":"Garrido Colmenero","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaad.2013.10.001","article-title":"The methotrexate polyglutamate assay supports the efficacy of methotrexate for severe inflammatory skin disease in children","volume":"70","author":"Rahman","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-38","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1365-2133.2012.11048.x","article-title":"Type III procollagen amino terminal propeptide: what does it measure in children?","volume":"167","author":"Wootton","year":"2012","journal-title":"Br J Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-39","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/bjd.12905","article-title":"Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis","volume":"170","author":"Maybury","year":"2014","journal-title":"Br J Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1525-1470.2011.01488.x","article-title":"Systemic treatment of pediatric atopic dermatitis with azathioprine and mycophenolate mofetil","volume":"28","author":"Waxweiler","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00003495-200969030-00005","article-title":"Systemic therapy of atopic dermatitis in children","volume":"69","author":"Ricci","year":"2009","journal-title":"Drugs"},{"key":"key-10.1136\/archdischild-2016-312106-42","first-page":"793","article-title":"Promoting medication adherence in children","volume":"74","author":"Gardiner","year":"2006","journal-title":"Am Fam Physician"},{"key":"key-10.1136\/archdischild-2016-312106-43","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaad.2016.04.054","article-title":"Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): a phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)","volume":"75","author":"Simpson","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-44","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaad.2014.08.038","article-title":"Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches","volume":"71","author":"Sidbury","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"(2)","key":"key-10.1136\/archdischild-2016-312106-45","first-page":"CD008774","article-title":"Specific allergen immunotherapy for the treatment of atopic eczema","author":"Tam","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/archdischild-2016-312106-46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamapediatrics.2015.3092","article-title":"Melatonin supplementation for children with atopic dermatitis and sleep disturbance: a randomized clinical trial","volume":"170","author":"Chang","year":"2016","journal-title":"JAMA Pediatr"},{"key":"key-10.1136\/archdischild-2016-312106-47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000446836","article-title":"Apremilast use for moderate-to-severe atopic dermatitis in pediatric patients","volume":"8","author":"Saporito","year":"2016","journal-title":"Case Rep Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-48","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12906-016-1158-1","article-title":"Characteristics of traditional Chinese medicine users and prescription analysis for pediatric atopic dermatitis: a population-based study","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Complement Altern Med"},{"key":"key-10.1136\/archdischild-2016-312106-49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2013.01.019","article-title":"Chinese herbal medicine for atopic dermatitis: a systematic review","volume":"69","author":"Tan","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"(9)","key":"key-10.1136\/archdischild-2016-312106-50","first-page":"CD008642","article-title":"Chinese herbal medicine for atopic eczema","author":"Gu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/archdischild-2016-312106-51","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/09546630510038938","article-title":"A survey of traditional Chinese medicine use in children with atopic dermatitis attending a paediatric dermatology clinic","volume":"16","author":"Hon","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"key-10.1136\/archdischild-2016-312106-52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jep.2014.11.018","article-title":"Use of traditional Chinese medicine reduces exposure to corticosteroid among atopic dermatitis children: a 1-year follow-up cohort study","volume":"159","author":"Chen","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"key-10.1136\/archdischild-2016-312106-53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-4362.1999.00732.x","article-title":"A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis","volume":"38","author":"Fung","year":"1999","journal-title":"Int J Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00228-012-1353-z","article-title":"Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews","volume":"69","author":"Posadzki","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.1136\/archdischild-2016-312106-55","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jamapediatrics.2015.3943","article-title":"Synbiotics for prevention and treatment of atopic dermatitis: a meta-analysis of randomized clinical trials","volume":"170","author":"Chang","year":"2016","journal-title":"JAMA Pediatr"},{"key":"key-10.1136\/archdischild-2016-312106-56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4168\/aair.2014.6.3.208","article-title":"Efficacy of probiotic therapy on atopic dermatitis in children: a randomized, double-blind, placebo-controlled trial","volume":"6","author":"Yang","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"key-10.1136\/archdischild-2016-312106-57","article-title":"Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4\u201348\u2005months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study","author":"Wu","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"key-10.1136\/archdischild-2016-312106-58","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jdv.12496","article-title":"Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies","volume":"29","author":"Panduru","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.1136\/archdischild-2016-312106-59","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cea.12489","article-title":"Children with atopic dermatitis show clinical improvement after Lactobacillus exposure","volume":"45","author":"Wang","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"key-10.1136\/archdischild-2016-312106-60","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/MPG.0b013e3181cea52b","article-title":"Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis","volume":"50","author":"Alexander","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key-10.1136\/archdischild-2016-312106-61","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2230.2005.02002.x","article-title":"Dietary restriction and supplementation in children with atopic eczema","volume":"31","author":"Hon","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"key-10.1136\/archdischild-2016-312106-62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaad.2010.11.020","article-title":"Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report","volume":"64","author":"Boyce","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"key-10.1136\/archdischild-2016-312106-63","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bjd.12932","article-title":"Therapeutic patient education in atopic eczema","volume":"170","author":"Barbarot","year":"2014","journal-title":"Br J Dermatol"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2016-312106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T14:43:28Z","timestamp":1719067408000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2016-312106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":63,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,24]]},"published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1136\/archdischild-2016-312106"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2016-312106","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]}}}